AUPN616195A0 - Method and composition for treatment of ocular diseases - Google Patents

Method and composition for treatment of ocular diseases

Info

Publication number
AUPN616195A0
AUPN616195A0 AUPN6161A AUPN616195A AUPN616195A0 AU PN616195 A0 AUPN616195 A0 AU PN616195A0 AU PN6161 A AUPN6161 A AU PN6161A AU PN616195 A AUPN616195 A AU PN616195A AU PN616195 A0 AUPN616195 A0 AU PN616195A0
Authority
AU
Australia
Prior art keywords
treatment
composition
ocular diseases
ocular
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN6161A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alchemia Oncology Pty Ltd
Original Assignee
Lions Eye Institute of Western Australia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lions Eye Institute of Western Australia Inc filed Critical Lions Eye Institute of Western Australia Inc
Priority to AUPN6161A priority Critical patent/AUPN616195A0/en
Publication of AUPN616195A0 publication Critical patent/AUPN616195A0/en
Priority to MYPI96004371A priority patent/MY134778A/en
Priority to PCT/AU1996/000664 priority patent/WO1997015330A1/en
Priority to CA002235685A priority patent/CA2235685A1/en
Priority to JP9516137A priority patent/JP2000507915A/en
Priority to CN96199290A priority patent/CN1209068A/en
Priority to KR1019980702900A priority patent/KR19990066967A/en
Priority to NZ320006A priority patent/NZ320006A/en
Priority to AU72664/96A priority patent/AU721060B2/en
Priority to EP96934189A priority patent/EP0859636A4/en
Priority to ZA968902A priority patent/ZA968902B/en
Assigned to HYAL PHARMACEUTICAL AUSTRALIA LIMITED reassignment HYAL PHARMACEUTICAL AUSTRALIA LIMITED Assignment by Applicant under S 113 Assignors: LIONS EYE INSTITUTE
Assigned to HYAL PHARMACEUTICAL AUSTRALIA LIMITED reassignment HYAL PHARMACEUTICAL AUSTRALIA LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: LIONS EYE INSTITUTE
Abandoned legal-status Critical Current

Links

AUPN6161A 1995-10-23 1995-10-23 Method and composition for treatment of ocular diseases Abandoned AUPN616195A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AUPN6161A AUPN616195A0 (en) 1995-10-23 1995-10-23 Method and composition for treatment of ocular diseases
EP96934189A EP0859636A4 (en) 1995-10-23 1996-10-22 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
PCT/AU1996/000664 WO1997015330A1 (en) 1995-10-23 1996-10-22 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
MYPI96004371A MY134778A (en) 1995-10-23 1996-10-22 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
CA002235685A CA2235685A1 (en) 1995-10-23 1996-10-22 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
JP9516137A JP2000507915A (en) 1995-10-23 1996-10-22 Hyaluronic acid as a DNA carrier for gene therapy and VEGF antisense DNA for treating abnormal retinal neovascularization
CN96199290A CN1209068A (en) 1995-10-23 1996-10-22 Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization
KR1019980702900A KR19990066967A (en) 1995-10-23 1996-10-22 Gene therapy for treating abnormal retinal angiogenesis and hyaluronic acid used as a DNA carrier for VEGF antisense
NZ320006A NZ320006A (en) 1995-10-23 1996-10-22 An adjuvant composition comprising hyaluronic acid for gene therapy either in the sense or antisense direction
AU72664/96A AU721060B2 (en) 1995-10-23 1996-10-22 Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization
ZA968902A ZA968902B (en) 1995-10-23 1996-10-23 Methods and compositions for treatment of diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN6161A AUPN616195A0 (en) 1995-10-23 1995-10-23 Method and composition for treatment of ocular diseases

Publications (1)

Publication Number Publication Date
AUPN616195A0 true AUPN616195A0 (en) 1995-11-16

Family

ID=3790488

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN6161A Abandoned AUPN616195A0 (en) 1995-10-23 1995-10-23 Method and composition for treatment of ocular diseases

Country Status (2)

Country Link
AU (1) AUPN616195A0 (en)
ZA (1) ZA968902B (en)

Also Published As

Publication number Publication date
ZA968902B (en) 1997-05-28

Similar Documents

Publication Publication Date Title
AU4582797A (en) Methods for treatment of retinal diseases
AU5540594A (en) Method of performing ophthalmic surgery
AU6952896A (en) Method for treatment of cancer and infectious diseases and compositions useful in same
AUPN271295A0 (en) Method of treatment
AU9028798A (en) Method of improving drug treatment
AU2277595A (en) Device and method for treatment of skin
AU5439996A (en) Compositions and methods for treating pain
AU2296995A (en) Composition and method for treatment of cmv infection
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
AU3681095A (en) Method and pharmaceutical composition for prevention and treatment of brain damage
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
AU4946699A (en) Method of treating meniere's disease and corresponding apparatus
AU6168296A (en) Chloroquine analogs and methods of preventing and treating p lasmodial disease
AU3607597A (en) Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
AU5713196A (en) Method for treatment of pain
AU4939296A (en) Method of reducing prolonged coagulation time
AU5699396A (en) Compositions for the treatment of skin conditions
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU6963596A (en) Method and composition for the manufactue of ophthalmic lenses
AU5293293A (en) Methods and compositions for treatment of allergic disease
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease
AUPN616195A0 (en) Method and composition for treatment of ocular diseases
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU7985698A (en) Methods for treatment of ocular neovascularization
AU2992295A (en) Therapeutic method and compounds of use therein